<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Successful Treatment of Erlotinib on Metastatic Adenoid Cystic Carcinoma of the Lacrimal Gland.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Successful Treatment of Erlotinib on Metastatic Adenoid Cystic Carcinoma of the Lacrimal Gland." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/303e/6048923/5a06b9be7775/CMJ-131-1746-g001.jpg"/> </div> <div class="text-side"> <h1>Successful Treatment of Erlotinib on Metastatic Adenoid Cystic Carcinoma of the Lacrimal Gland.</h1> <p>Representative image of the patient who was diagnosed as lacrimal gland adenoid cystic carcinoma. (a) CT scan showed an orbital mass on the upper-right side (white arrow). (b) Tumor consisted of glandular or adenoid structure with basophilic secretion, with areas of cribriform, tubular, trabecular, solid, and basaloid structures (Hematoxylin and Eeosin [H&amp;E], ×200). (c) CT scan showed multi metastatic lesions in left lung and pleura (black arrow). (d) Tumor with cribriform structures invaded the pleural tissue (H&amp;E, ×200). (e) Metastatic lesions shrunk after 1-month of erlotinib therapy (black arrow). (f) Tumor maintained response at 14-month (black arrow). CT: Computerized tomography.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/29998897/" target="_blank">29998897</a></p><p>Type: Premalignant/Malignant, Category: Adnexal</p>
</div> </div></div></body></html>